1261 related articles for article (PubMed ID: 19440065)
1. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
2. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.
Huang SS; Huang PH; Chen YH; Sung SH; Chiang KH; Chen JW; Lin SJ
Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786
[TBL] [Abstract][Full Text] [Related]
3. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
[TBL] [Abstract][Full Text] [Related]
4. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
Falcone C; Emanuele E; D'Angelo A; Buzzi MP; Belvito C; Cuccia M; Geroldi D
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496
[TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index.
Brevetti G; Silvestro A; Schiano V; Chiariello M
Circulation; 2003 Oct; 108(17):2093-8. PubMed ID: 14530195
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
[TBL] [Abstract][Full Text] [Related]
8. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population.
Norata GD; Garlaschelli K; Grigore L; Tibolla G; Raselli S; Redaelli L; Buccianti G; Catapano AL
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):129-34. PubMed ID: 18595673
[TBL] [Abstract][Full Text] [Related]
9. Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients.
Yokota C; Minematsu K; Tomii Y; Naganuma M; Ito A; Nagasawa H; Yamaguchi T
J Neurol Sci; 2009 Dec; 287(1-2):41-4. PubMed ID: 19801152
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
[TBL] [Abstract][Full Text] [Related]
12. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
13. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score.
Raposeiras-Roubín S; Rodiño-Janeiro BK; Grigorian-Shamagian L; Moure-González M; Seoane-Blanco A; Varela-Román A; Almenar-Bonet L; Alvarez E; González-Juanatey JR
Am J Cardiol; 2011 Mar; 107(6):938-44. PubMed ID: 21247530
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation.
Karatzis EN; Ikonomidis I; Vamvakou GD; Papaioannou TG; Protogerou AD; Andreadou I; Voidonikola PT; Karatzi KN; Papamichael CM; Lekakis JP
Am J Cardiol; 2006 Dec; 98(11):1424-8. PubMed ID: 17126643
[TBL] [Abstract][Full Text] [Related]
15. Plasma N-epsilon-(carboxymethyl)lysine levels are associated with the extent of vessel injury after coronary arterial stenting.
Basta G; Berti S; Cocci F; Lazzerini G; Parri S; Papa A; Battaglia D; Lubrano V; Del Turco S; Ravani M; Rizza A; De Caterina R; Marraccini P; Mazzone A
Coron Artery Dis; 2008 Aug; 19(5):299-305. PubMed ID: 18607166
[TBL] [Abstract][Full Text] [Related]
16. Peripheral vascular endothelial function testing for the diagnosis of coronary artery disease.
Jambrik Z; Venneri L; Varga A; Rigo F; Borges A; Picano E
Am Heart J; 2004 Oct; 148(4):684-9. PubMed ID: 15459601
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient.
Fichtlscherer S; Breuer S; Zeiher AM
Circulation; 2004 Oct; 110(14):1926-32. PubMed ID: 15451794
[TBL] [Abstract][Full Text] [Related]
18. Plasma nitroso compounds are decreased in patients with endothelial dysfunction.
Heiss C; Lauer T; Dejam A; Kleinbongard P; Hamada S; Rassaf T; Matern S; Feelisch M; Kelm M
J Am Coll Cardiol; 2006 Feb; 47(3):573-9. PubMed ID: 16458138
[TBL] [Abstract][Full Text] [Related]
19. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
20. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Hernanz A; De la Fuente M; Navarro M; Frank A
Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
